Back to funds
View filing
Ally Bridge Group (NY) LLC
hedge fundUpdated 28 days agoManaged by Ally Bridge Group (Ny) Llc • Latest filing Q2 2026
Portfolio value
$113.1M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
68.6%
Weight of largest holdings
Annualized return
8.7%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $76.3M |
| Q2 2023 | $82.6M |
| Q3 2023 | $85.2M |
| Q4 2023 | $167.8M |
| Q1 2024 | $179.9M |
| Q2 2024 | $167.9M |
| Q3 2024 | $186.8M |
| Q4 2024 | $116.6M |
| Q1 2025 | $110.9M |
| Q2 2025 | $120.2M |
| Q3 2025 | $164.2M |
| Q4 2025 | $96M |
| Q1 2026 | $123.8M |
| Q2 2026 | $113.1M |
Top holdings
25 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DFTX DEFINIUM THERAPEUTICS INC | $18.8M | 400.0K | 16.64% | — |
| 2 | A AAVXF ABIVAX SA | $16.7M | 125.0K | 14.73% | — |
| 3 | N NERV MINERVA NEUROSCIENCES INC | $12.1M | 2.18M | 10.68% | — |
| 4 | P PMN PROMIS NEUROSCIENCES INC | $8.2M | 620.3K | 7.22% | — |
| 5 | ? N/A FIRST TRACKS BIOTHERAPEUTICS | $5.7M | 284.3K | 5.06% | — |
| 6 | A AXSM AXSOME THERAPEUTICS INC | $4M | 16.5K | 3.57% | — |
| 7 | A ASH ASSEMBLY BIOSCIENCES INC | $3.8M | 140.0K | 3.40% | — |
| 8 | ? N/A WHITEHAWK THERAPEUTICS INC | $3.7M | 817.9K | 3.31% | — |
| 9 | E EWTX EDGEWISE THERAPEUTICS INC | $3.4M | 83.3K | 2.99% | — |
| 10 | ? N/A CLIMB BIO INC | $3.2M | 249.2K | 2.87% | — |
| 11 | K KURA KURA ONCOLOGY INC | $3.2M | 290.0K | 2.81% | — |
| 12 | C CTMX CYTOMX THERAPEUTICS INC. | $2.9M | 775.0K | 2.57% | — |
| 13 | A AVTX AVALO THERAPEUTICS INC | $2.8M | 150.0K | 2.45% | — |
| 14 | ? N/A PALISADE BIO INC | $2.6M | 1.23M | 2.27% | — |
| 15 | S SLDB SOLID BIOSCIENCES INC | $2.6M | 256.0K | 2.26% | — |
| 16 | ? N/A AN2 THERAPEUTICS INC | $2.5M | 526.3K | 2.25% | — |
| 17 | U URGN UROGEN PHARMA LTD | $2.5M | 69.2K | 2.25% | — |
| 18 | ? N/A PERSPECTIVE THERAPEUTICS INC | $2.5M | 744.0K | 2.24% | — |
| 19 | I IDYA IDEAYA BIOSCIENCES INC | $2.5M | 67.5K | 2.22% | — |
| 20 | I IVEVF INVENTIVA SA | $2.4M | 634.8K | 2.12% | — |